Eloy Catarina, Ferreira Luciana, Salgado Catarina, Soares Paula, Sobrinho-Simões Manuel
Institute of Molecular Pathology and Immunology of the University of Porto, Cancer Biology, Porto, Portugal.
Turk Patoloji Derg. 2015;31 Suppl 1:48-59. doi: 10.5146/tjpath.2015.01314.
Thyroid cancer is the most common endocrine malignancy and its incidence goes on increasing worldwide. The majority of thyroid tumours comprise well-differentiated (papillary and follicular) thyroid carcinomas that usually carry an excellent prognosis, while a minority progress to poorly differentiated carcinoma (PDTC) and, ultimately, to the highly aggressive and lethal undifferentiated carcinoma (UTC). Recently, some major advances have been made on the histologic and imunohistochemical identification, as well as on the molecular characterization of PDTC and UTC. In this review we summarize the most recent immunohistochemical and molecular findings in PDTC and UTC, giving a particular emphasis to the diagnostic and prognostic meaning of the genetic alterations.
甲状腺癌是最常见的内分泌恶性肿瘤,其发病率在全球范围内持续上升。大多数甲状腺肿瘤为分化良好的(乳头状和滤泡状)甲状腺癌,通常预后良好,而少数会进展为低分化癌(PDTC),最终发展为具有高度侵袭性和致命性的未分化癌(UTC)。最近,在PDTC和UTC的组织学和免疫组化鉴定以及分子特征方面取得了一些重大进展。在本综述中,我们总结了PDTC和UTC中最新的免疫组化和分子研究结果,特别强调了基因改变的诊断和预后意义。